Dysmenorrhea

·MeSH: Dysmenorrhea

8 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
celecoxib	AlphaTON Capital Corp (ATON)
celecoxib	Zomedica Corp. (ZOMDF)
celecoxib	Aptinyx Inc. (APTX)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	Miromatrix Medical Inc. (MIRO)
diclofenac	Zomedica Corp. (ZOMDF)

Phase 3(1)

Drug	Company
Xeomin	Revance Therapeutics, Inc. (RVNC)

Phase 4(1)

Drug	Company
Sodium Naproxen	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 8 drugs in development for Dysmenorrhea across 7 companies.

There are 2 clinical trials targeting Dysmenorrhea tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.